scholarly journals Endocarditis Caused by Gram-NegativeMoraxella osloensisin an Immunocompetent Patient: First Case Report in Latin America

2018 ◽  
Vol 2018 ◽  
pp. 1-3
Author(s):  
Patricia Fraga Paiva ◽  
Carolina Fraga Paiva ◽  
Emanoel Guimarães Paiva ◽  
Gisele Maria Campos Fabri ◽  
José Fabri Junior
Keyword(s):  
Latin America ◽  
Case Report ◽  
Infective Endocarditis ◽  
Young Adult ◽  
Immunocompetent Patient ◽  
Moraxella Osloensis ◽  
First Case ◽  
Focus Of Infection

This is a case report of infective endocarditis due toMoraxella osloensis. This study would be the fourth since the two latest episodes were described in 2015. The patient of this exposition is different from those previously described in the literature because it was a young adult, under 50 years of age, immunocompetent, with no comorbidities and no obvious focus of infection.

scholarly journals Subcutaneous phaeohyphomycosis due to Cladophialophora bantiana: a first case report in an immunocompetent patient in Latin America and a brief literature review

2019 ◽  
Vol 52 ◽  
Author(s):  
Gustavo Ávila Maquiné ◽  
Marcos Henrique Gurgel Rodrigues ◽  
Antônio Pedro Mendes Schettini ◽  
Patricia Motta de Morais ◽  
Maria Zeli Moreira Frota
Keyword(s):  
Latin America ◽  
Case Report ◽  
Literature Review ◽  
Immunocompetent Patient ◽  
First Case ◽  
Subcutaneous Phaeohyphomycosis

scholarly journals Disseminated toxoplasmosis in an immunocompetent patient from Peruvian Amazon

2010 ◽  
Vol 52 (2) ◽  
pp. 107-110 ◽  
Author(s):  
Juan Nunura ◽  
Tania Vásquez ◽  
Sergio Endo ◽  
Daniela Salazar ◽  
Alejandrina Rodriguez ◽  
...  
Keyword(s):  
Visual Acuity ◽  
Case Report ◽  
Muscle Biopsy ◽  
Blood Smear ◽  
Immunocompetent Patient ◽  
Peruvian Amazon ◽  
Thick Blood Smear ◽  
First Case ◽  
Hip Extension

We report a case of severe toxoplasmosis in an immunocompetent patient, characterized by pneumonia, retinochoroiditis, hepatitis and myositis. Diagnosis was confirmed by serology, T. gondii in thick blood smear and presence of bradyzoites in muscle biopsy. Treatment with pyrimethamine plus sulfadoxine was successful but visual acuity and hip extension were partially recovered. This is the first case report of severe toxoplasmosis in an immunocompetent patient from Peru.

scholarly journals First case report of Nocardia brasiliensis infection causing necrotizing fasciitis in an immunocompetent patient

2016 ◽  
Vol 49 (5) ◽  
pp. 824-825 ◽  
Author(s):  
Yung-Cheng Lin ◽  
Zheng-Yi Huang ◽  
Jun-Ren Sun ◽  
Ching-Mei Yu ◽  
Ching-Hsun Wang
Keyword(s):  
Case Report ◽  
Necrotizing Fasciitis ◽  
Immunocompetent Patient ◽  
Nocardia Brasiliensis ◽  
First Case

Cervical spondylitis due to Phaeoacremonium venezuelense in an immunocompetent patient. A first case report

2012 ◽  
Vol 22 (2) ◽  
pp. 197-200 ◽  
Author(s):  
K. Mostofi ◽  
D. Blanchet ◽  
D. Marnet ◽  
P. Abboud ◽  
D. Jeanbourquin ◽  
...  
Keyword(s):  
Case Report ◽  
Immunocompetent Patient ◽  
First Case

scholarly journals A SMARCA2 Mutation in the First Case Report of Nicolaides-Baraitser Syndrome in Latin America: Genotype-Phenotype Correlation

2017 ◽  
Vol 2017 ◽  
pp. 1-4 ◽  
Author(s):  
Ana Isabel Sánchez ◽  
Jorge Armando Rojas
Keyword(s):  
Latin America ◽  
Case Report ◽  
Language Impairment ◽  
De Novo ◽  
Signs And Symptoms ◽  
Facial Features ◽  
Missense Mutations ◽  
De Novo Mutations ◽  
Lower Lip ◽  
First Case

Nicolaides-Baraitser syndrome (NCBRS) is a rare and well-recognized entity that was first described in 1993, with a prevalence that is currently not known. It is recognized as a distinctive entity, with some variability in its signs and symptoms. The most important characteristics include intellectual disability, peculiar facial features including sparse scalp hair, coarse facial features, low frontal hairline, and microcephaly, and seizures. Additional features may include epicanthic folds, thin upper lip vermilion with thick lower lip vermilion, skeletal abnormalities, and severe language impairment. The disorder is inherited in an autosomal dominant manner caused by de novo mutations in the SMARCA2 gene, with most being missense mutations. We report a young adult patient with NCBRS and, to our knowledge, the first case report of the syndrome in Latin America with a confirmed molecular diagnosis and a mild-to-moderate phenotype.

scholarly journals Idarucizumab to revert the anticoagulant effect of dabigatran in traumatic acute subdural haematoma: a case report of first use in Latin America

2019 ◽  
Vol 3 (2) ◽  
Author(s):  
Raúl Izaguirre Ávila ◽  
José Eduardo Bahena López ◽  
Evelyn Cortina de la Rosa ◽  
Miguel Ángel Hernández Márquez
Keyword(s):  
Latin America ◽  
Case Report ◽  
Emergency Surgery ◽  
Subdural Haematoma ◽  
Vitamin K Antagonists ◽  
Attractive Alternative ◽  
Venous Disease ◽  
First Case ◽  
Increased Risk ◽  
Life Threatening

Abstract Background  Direct oral anticoagulants (DOAC) are an attractive alternative over vitamin K antagonists. They have several advantages in primary and secondary prevention of thromboembolisms due to atrial fibrillation, as well as in prevention and treatment of thromboembolic venous disease. They have fast onset action, do not need laboratory controls in patients with normal renal function, and they have practically no interference with the patient’s diet or medications. The strongest objection to their use was the lack of reversal agents that could be used in case of life-threatening haemorrhage or the need for emergency surgery. Dabigatran was the first DOAC to have its own specific reversal agent: idarucizumab, a monoclonal antibody. Case summary  We report here the case of a patient undergoing treatment with dabigatran that suffered an expansive subdural haematoma secondary to a cranial injury. The condition was life-threatening and required emergency surgery. Anticoagulation was successfully reversed with idarucizumab. Discussion  Emergency surgery in patients in treatment with DOAC is associated with an increased risk of bleeding. With the use of a specific antidote to block the action of the anticoagulant, as in the case of idarucizumab with dabigatran, the risk of complications during and after emergency surgery is reduced. This is the first case report with which the successful use of idarucizumab in Latin America is documented.

scholarly journals First case report of fulminant septic shock from meningococcemia associated with Cryptococcus neoformans coinfection in an immunocompetent patient

2019 ◽  
Vol 26 ◽  
pp. 44-46
Author(s):  
Guilherme Dienstmann ◽  
Karina Tolfo Avi ◽  
Luiz Arthur Calheiros Leite ◽  
Joaquim Squizatto Alano ◽  
Matheus Leite Ramos de Souza ◽  
...  
Keyword(s):  
Septic Shock ◽  
Case Report ◽  
Cryptococcus Neoformans ◽  
Immunocompetent Patient ◽  
First Case
Sign in / Sign up

Export Citation Format

Share Document